The COVID-19 pandemic, while upending nearly aspect of life, is highlighting the pace which health care companies are innovating. These companies are vastly expediting regulatory processes and applying pressure to supply ecosystems to deliver health care innovations in new and exciting ways.
During this webinar with Portfolio Manager Andy Acker, you will learn about:
•Complex and evolving nature of the COVID-19 crisis leading to changing market dynamics
•How the pandemic has supercharged innovation within health care as it seeks to address unmet medical needs
•The power of deep, fundamental research to uncover the most compelling opportunities across the life sciences spectrum while also integrating a framework that focuses on downside risks.